首页> 外文期刊>Journal of the American Chemical Society >Organic Arsenicals As Efficient and Highly Specific Linkers for Protein/Peptide-Polymer Conjugation
【24h】

Organic Arsenicals As Efficient and Highly Specific Linkers for Protein/Peptide-Polymer Conjugation

机译:有机砷作为蛋白质/肽-聚合物缀合的高效和高度特异性接头

获取原文
获取原文并翻译 | 示例
       

摘要

The entropy-driven affinity of trivalent (in) organic arsenicals for closely spaced dithiols has been exploited to develop a novel route to peptide/protein-polymer conjugation. A trivalent arsenous acid (As(Ⅲ)) derivative (1) obtained from p-arsanilic acid (As(Ⅴ)) was shown to readily undergo conjugation to the therapeutic peptide salmon calcitonin (sCT) via bridging of the Cys~1-Cys~7 disulfide, which was verified by RP-HPLC and MALDI-ToF-MS. Conjugation was shown to proceed rapidly (t < 2 min) in situ and stoichiometrically through sequential reduction-conjugation protocols, therefore exhibiting conjugation efficiencies equivalent to those reported for the current leading disulfide-bond targeting strategies. Furthermore, using bovine serum albumin as a model protein, the trivalent organic arsenical 1 was found to demonstrate enhanced specificity for disulfide-bond bridging in the presence of free cysteine residues relative to established maleimide functional reagents. This specificity represents a shift toward potential orthogonality, by clearly distinguishing between the reactivity of mono- and disulfide-derived (vicinal or neighbors-through-space) dithiols. Finally, p-arsanilic acid was transformed into an initiator for aqueous single electron-transfer living radical polymerization, allowing the synthesis of hydrophilic arsenic-functional polymers which were shown to exhibit negligible cytotoxicity relative to a small molecule organic arsenical, and an unfunctionalized polymer control. Poly(poly[ethylene glycol] methyl ether acrylate) (PPEGA_(480), DP_n = 10, M_(n,NMR) = 4900 g· mol~(-1), D = 1.07) possessing a pentavalent arsenic acid (As(Ⅴ)) α-chain end was transformed into trivalent As(Ⅲ) post-polymerization via initial reduction by biological reducing agent glutathione (GSH), followed by binding of GSH. Conjugation of the resulting As(Ⅲ)-functional polymer to sCT was realized within 35 min as indicated by RP-HPLC and verified later by thermodynamically driven release of sCT, from the conjugate, in the presence of strong chelating reagent ethanedithiol.
机译:熵驱动的三价有机砷类化合物对紧密排列的二硫醇的亲和力已被开发出来,以开发一种新的肽/蛋白质-聚合物结合途径。由对砷酸(As(Ⅴ))制得的三价砷酸(As(Ⅲ))衍生物(1)经Cys〜1-Cys桥联后易于与治疗性肽鲑降钙素(sCT)结合。 〜7二硫化物,已通过RP-HPLC和MALDI-ToF-MS验证。通过连续的还原-偶联方案,偶联反应在原位和化学计量上迅速进行(t <2分钟),因此其偶联效率与当前领先的二硫键靶向策略所报道的效率相同。此外,使用牛血清白蛋白作为模型蛋白,发现三价有机砷1相对于已建立的马来酰亚胺功能试剂,在存在游离半胱氨酸残基的情况下显示出对二硫键桥接的增强的特异性。通过清楚地区分一硫化物和二硫化物衍生的(邻位邻域或邻域邻域)二硫醇的反应性,该特异性代表了向潜在正交性的转变。最后,将对麻油酸转化为用于水性单电子转移活性自由基聚合的引发剂,从而实现了亲水性砷官能聚合物的合成,相对于小分子有机砷,其表现出可忽略的细胞毒性,而未官能化的聚合物控制。具有五价砷酸(As(A(n(-(n,NMR))= 4900 g·mol〜(-1),D = 1.07)的聚(聚乙二醇)甲基醚丙烯酸酯) Ⅴ))通过生物还原剂谷胱甘肽(GSH)的初步还原,α-链末端被转化为三价As(Ⅲ),然后与GSH结合。如RP-HPLC所示,在35分钟内实现了所得的具有As(Ⅲ)-官能的聚合物与sCT的缀合,随后在强螯合剂乙二硫醇的存在下,通过热力学驱动sCT从缀合物中释放来验证。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2015年第12期|4215-4222|共8页
  • 作者单位

    Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom,ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia;

    Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom,ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia;

    Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom;

    Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom,ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia;

    Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom,ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia;

    ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia;

    ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia;

    ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia;

    Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom,ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia;

    Lowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia;

    Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom,ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号